OceƱa, Heintje .
HRN: 24-18-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2023
12/11/2023
IV
4.5g
Q6
CAP-MR; Immunicompromised State
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes